GL Pharma is a proudly independent Austrian pharmaceutical company, powered by science, research, and innovation.

As a leading European specialty pharmaceutical company, we have a direct presence in over 18 countries, with ambitious plans for further geographic expansion. This growth aligns with our mission to solidify our position as a leader in value-added medicines across critical therapeutic areas such as severe pain, opioid substitution therapy (OST), epilepsy, and more.

From our headquarters in Lannach, Austria, we develop and deliver high-quality medicines. Our expertise spans the production of niche generics and active research into diverse therapeutic areas. At GL Pharma, we are proud to manufacture both finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs) at our state-of-the-art facilities.

Discover more about our journey and commitment to advancing healthcare by visiting us at gl-pharma.com.

For details about our privacy policy on LinkedIn, please see: https://gl-pharma.com/wp-content/uploads/2023/11/Datenschutzerklarung-LinkedIn.pdf

GL Pharma

Org chart

Teams

Offices